Featured Research

from universities, journals, and other organizations

Control of cellular recycling pathways

Date:
March 26, 2013
Source:
Albert-Ludwigs-Universität Freiburg
Summary:
In a new study, researchers shed light on the highly organized and complicated regulation of cellular turnover.

Together with researchers from the University of Rome/Italy and the Italian National Institute for Infectious Diseases, scientists from the Freiburg Institute for Advanced Studies (FRIAS) and the Center for Biological Systems Analysis (ZBSA) shed light onto the highly organized and complicated regulation of cellular turnover. Work contributed by the Freiburg-based research group led by biochemist Dr. Jörn Dengjel, Junior Fellow of the FRIAS School of Life Sciences -- LifeNet, has just been published in the journal Nature Cell Biology.

Bio-molecules within human cells are constantly being synthesized and degraded. This turnover is important for basic cellular processes, but it also plays a role in stress responses. Its deregulation has been linked to several diseases, amongst others cancer and neurodegenerative disorders like Parkinson's. By combining analytical and cell biological approaches, the international research team between Freiburg and Rome identified a new pathway regulating protein interactions and their influence on cellular recycling.

One of the recycling pathways, autophagy or cellular "self digestion," has been a focus of Jörn Dengjel's research for many years. In times of poor energy supply, this self digestion helps to secure the cells' survival. A protein that plays an important role in autophagy regulation is AMBRA1. In their paper, the Freiburg-based research group identified a dynamic phosphorylation site on the protein AMBRA1. Dengjel's Italian colleagues could further show that during growth factor shortage phosphorylation on this specific site is removed, activating AMBRA1, which in turn leads to increased cellular turnover and survival of the cells.

Jörn Dengjel has been conducting research as Junior Fellow of the FRIAS School of Life Sciences -- LifeNet since 2008. At the ZBSA he is leading the research group "Spatio-temporal protein dynamics during autophagy."


Story Source:

The above story is based on materials provided by Albert-Ludwigs-Universität Freiburg. Note: Materials may be edited for content and length.


Journal Reference:

  1. Francesca Nazio, Flavie Strappazzon, Manuela Antonioli, Pamela Bielli, Valentina Cianfanelli, Matteo Bordi, Christine Gretzmeier, Joern Dengjel, Mauro Piacentini, Gian Maria Fimia, Francesco Cecconi. mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6. Nature Cell Biology, 2013; DOI: 10.1038/ncb2708

Cite This Page:

Albert-Ludwigs-Universität Freiburg. "Control of cellular recycling pathways." ScienceDaily. ScienceDaily, 26 March 2013. <www.sciencedaily.com/releases/2013/03/130326112054.htm>.
Albert-Ludwigs-Universität Freiburg. (2013, March 26). Control of cellular recycling pathways. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/03/130326112054.htm
Albert-Ludwigs-Universität Freiburg. "Control of cellular recycling pathways." ScienceDaily. www.sciencedaily.com/releases/2013/03/130326112054.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins